REVITACARE
Revitacare, founded in 2003 and headquartered in Saint-Ouen-l'Aumône, France, is a prominent laboratory specializing in the research, development, and production of medical devices and cosmetic products based on hyaluronic acid. The company is renowned for its innovative solutions aimed at preventing and correcting skin aging and treating hair problems. Revitacare's product portfolio includes the acclaimed Cytocare line, which is widely recognized for its efficacy in skin rejuvenation and hydration. Other notable products include Haircare, a treatment designed to promote hair growth, and Revitafill Xtra, a line of monophasic fillers with amino acids. These products are developed using exclusive components of active ingredients, ensuring high performance and safety. In 2017, Revitacare was acquired by Bloomage Biotech, a leading Chinese company in hyaluronic acid production. This acquisition has expanded Revitacare's reach and enhanced its product offerings, allowing for greater distribution and innovation in the global market. The company remains committed to quality, with ISO 13485 certification ensuring that its products meet stringent regulatory standards.
REVITACARE Introduction
Founded in 2003, REVITACARE is a French Laboratory, with specializing in research, design, manufacturing of medical devices based on hyaluronic acid, dedicated to aesthetic medicine and cosmetology to prevent, correct the skin aging and treat hair problems. Their medical devices comply with the essential requirements of the Council Directive 93/42/ECC concerning medical devices and its amendments and carry ISO 13485 certification. The company owns a rich product portfolio. The most popular brand is Cytocare, a range of resorbable implants composed of hyaluronic acid and rejuvenating complex ideal for treating fine lines, wrinkles, and dehydrated skin.